Alzheimer's Disease Trial, Recruiting NCT06862557 Sponsor: Herrick Medical LLC Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06862557
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 50 years of age or older
  • You have been diagnosed with mild to moderate Alzheimer's disease, Lewy body dementia, or vascular dementia (confirm with trial site for exact diagnosis criteria)
  • You completed at least an 8th grade education
  • If you are female, you have gone through menopause
  • Your score on a standard memory and thinking test (called the MMSE) is between 16 and 26
  • You are able to give your own consent to participate, or you have a spouse or family member who can give consent on your behalf if needed
  • You are willing and able to follow the study's requirements
  • If you are taking certain dementia medications (cholinesterase inhibitors and/or memantine), you have been on a stable dose for at least 60 days and have been prescribed them for at least 3 months before joining
  • A doctor has confirmed you are physically able to take part in the study

Who may not be able to join:

  • You cannot give consent yourself and there is no one available to consent on your behalf
  • You do not have a person in your life who could be interviewed as part of the study
  • You have a history of epilepsy or seizures
  • You have been diagnosed with frontotemporal dementia
  • You are currently taking medication that lowers the threshold for seizures (excluding blood thinners)
  • You are currently taking anti-amyloid antibody treatments (past treatment may be acceptable if stopped at least 3 months ago — confirm with trial site)
  • You have a current or past history of depression, bipolar disorder, a psychotic disorder, or another neurological or psychiatric condition that the study doctor feels would interfere with the trial
  • You have severe agitation that would make it difficult to take part in study procedures
  • You have had an alcohol or substance use disorder within the last 5 years, or you have severe sleep deprivation
  • You have had major surgery requiring general anesthesia and more than one week in hospital within the last 4 weeks
  • The shape of your head does not allow the treatment device to fit properly (confirm with trial site)
  • You have taken part in another clinical trial within the last 30 days
  • You have metal implants in your head, such as cochlear implants, brain stimulators, or aneurysm clips (metal implants in the mouth are acceptable)
  • You have a condition that would make blood draws significantly more risky for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 561-869-6810

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Herrick Medical LLC
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
30 April 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov